Adaptive and maladaptive emotions in patients with cancer: identification of indicators (EMOCA study)
- Conditions
- adaptiviteit van emoties(mal)adaptive emotionsadjustment of emoties
- Registration Number
- NL-OMON54248
- Lead Sponsor
- Vrije Universiteit Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 160
- diagnosis of a solid malignancy cancer, (i) non-metastatic disease or (ii)
metastatic disease;
- between 3 and 7 months after start of treatment with (neo)adjuvant or 1st
line chemotherapy, or immunotherapy;
- life expectancy of more than 3 months.
- age*<*18;
- insufficient command of the Dutch language;
- severe psychopathology, other than mood or anxiety disorder (e.g. lifetime
history of bipolar disorder, schizophrenia, MDD with psychotic features,
schizoaffective disorders);
- severe cognitive impairments (e.g. dementia);
- patients with a (indication of) brain tumor or -metastases;
- a history of severe drug or alcohol abuse within past 6 months;
- not competent in the use of a mobile phone
- no informed consent.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Emotional symptoms, cancer-treatment-related symptoms and activities, specific<br /><br>signs and symptoms are identified by an oncologist and nurse through a<br /><br>checklist, life goals, diagnostic mental health interview, the need for<br /><br>professional mental health care, psychosocial symptoms and threatening<br /><br>experiences.</p><br>
- Secondary Outcome Measures
Name Time Method <p>sleep (problems), mastery (the feeling to which a person perceives himself or<br /><br>herself to be in control of events and ongoing situations), emotional<br /><br>reactivity in daily life, instrumental and social support.</p><br>